Osteoarthritis of knee. Osteoarthritis of knee
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Bilateral knee pain Individuals aged 40 to 65 years Presence of moderate osteoarthritis in the dominant or non-dominant knee confirmed by a physician based on radiographic imaging and clinical examinations Pain with a VAS score of 3 to 7 at the beginning of the study, reported on most days during the two weeks prior to the visit
Exclusion criteria
Exclusion criteria: Presence of intellectual disability in the participant (inability to comprehend test and exercise instructions) Patient being prohibited from receiving exercise therapy as per physician’s instructions Undergoing surgery within the past year on the knee receiving treatment Injection of hyaluronic acid gel or corticosteroids, or physiotherapy treatment in the affected knee within the past 6 months Patients with serious neurological disorders, tumors, fibromyalgia, or active infections involving the lower limbs Continuous use of non-steroidal anti-inflammatory drugs (NSAIDs) during the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Constant and absolute error of knee joint position sense. Timepoint: At the beginning of the study and at the end of the sixth week of treatment. Method of measurement: Constant and absolute error of knee joint position sense monitored via Biodex™ (Shirley, NY, United States) isokinet. | — |
Secondary
| Measure | Time frame |
|---|---|
| Passive knee joint range of motion. Timepoint: At the beginning of the study and at the end of the sixth week of treatment. Method of measurement: Dualler inclinometer.;Active knee joint range of motion. Timepoint: At the beginning of the study and at the end of the sixth week of treatment. Method of measurement: Dualler inclinometer.;Pain. Timepoint: At the beginning of the study and at the end of the sixth week of treatment. Method of measurement: Visual Analog Scale.;Knee joint stiffness. Timepoint: At the beginning of the study and at the end of the sixth week of treatment. Method of measurement: WOMAC questionnaire.;Physical function. Timepoint: At the beginning of the study and at the end of the sixth week of treatment. Method of measurement: WOMAC questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Semnan University of Medical Sciences